Recurrence of atrial fibrillation after switching from brand to generic atenolol

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Detalles Bibliográficos
Autores principales: Gallelli, Luca, Maida, Francesca, Staltari, Orietta, Rende, Pierandrea, Russo, Emilio, Caroleo, Benedetto, De Sarro, Giovambattista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319249/
https://www.ncbi.nlm.nih.gov/pubmed/25709353
http://dx.doi.org/10.4103/0976-500X.149146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319249/
https://www.ncbi.nlm.nih.gov/pubmed/25709353
http://dx.doi.org/10.4103/0976-500X.149146

Ejemplares similares